Respiratory system disease
Conditions
Interventions
An experimental group made up of 71 participants with SAR 2 infection will undergo ozone therapy and the conventional treatment established by WHO for Covid-19 will be compared and a group made up of
Other
Sponsors
Associação Brasileira de Ozonioterapia
Associação Brasileira de Ozonioterapia
Eligibility
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Man and women Age between 18 and 90 years; Signature of the informed consent form (ICF). COVID-19 positive PCR (Swab) exam
Exclusion criteria
Exclusion criteria: Pregnancy, especially in the beginning; Individuals who continuously use immunosuppressants or have been transplanted for less than 6 months; Individuals participating in other clinical studies. Symptoms of severe acute respiratory syndrome (SARS) and / or comorbidities according to the regulations of the Ministry of Health (Guidelines for Diagnosis and Treatment for COVID-19, version 1 of April 6, 2020), with suspicion of COVID-19, with Covid RT-PCR -19
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in the percentage of patients with suspected / confirmed COVID 19 who evolve to more severe forms (need for hospitalization and / or mechanical ventilation) with an increase in the recovery rate of these patients in the group who underwent ozone therapy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of the time of symptoms and reduction of the viral load by COVID 19 and its consequences. | — |
Countries
Brazil
Contacts
Public ContactArnoldo Souza
Associação Brasileira de Ozonioterapia
Outcome results
None listed